Algernon Pharmaceuticals (XTER:BTI) Other Long Term Assets : €0.02 Mil (As of Feb. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals Other Long Term Assets?

Algernon Pharmaceuticals's other long-term assets for the quarter that ended in Feb. 2024 was €0.02 Mil.

Algernon Pharmaceuticals's quarterly other long-term assets declined from Aug. 2023 (€0.04 Mil) to Nov. 2023 (€0.02 Mil) but then increased from Nov. 2023 (€0.02 Mil) to Feb. 2024 (€0.02 Mil).

Algernon Pharmaceuticals's annual other long-term assets increased from Aug. 2021 (€0.04 Mil) to Aug. 2022 (€0.04 Mil) but then declined from Aug. 2022 (€0.04 Mil) to Aug. 2023 (€0.04 Mil).

Algernon Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Algernon Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals Other Long Term Assets Chart

Algernon Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Other Long Term Assets

Get a 7-Day Free Trial

0.04

Algernon Pharmaceuticals Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Other Long Term Assets	Get a 7-Day Free Trial															0.18	0.17	0.04	0.02	0.02

Algernon Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Algernon Pharmaceuticals (XTER:BTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (XTER:BTI) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

AGNPF:USA AGW0:Germany AGN:Canada

Address

601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2

Website

https://www.algernonpharmaceuticals.com

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.